Bar-Shalom R. [Calcitonin nasal spray for Paget's disease of the bone]. Harefuah. 1995 Mar 15;128(6):358-62, 399. \[[PubMed: 7750816](https://pubmed.ncbi.nlm.nih.gov/7750816)\] 14. Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. Q J Med. 1981 Autumn;50(200):473-81. \[[PubMed: 7342172](https://pubmed.ncbi.nlm.nih.gov/7342172)\] 15. Wisneski LA. Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int. 1990;46 Suppl:S26-30. \[[PubMed: 2137363](https://pubmed.ncbi.nlm.nih.gov/2137363)\] 16. Bilezikian JP. Clinical review 51: Management of hypercalcemia. J Clin Endocrinol Metab. 1993 Dec;77(6):1445-9. \[[PubMed: 8263125](https://pubmed.ncbi.nlm.nih.gov/8263125)\] 17. Nilsson O, Almqvist S, Karlberg BE. Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man. Acta Med Scand. 1978;204(4):249-52. \[[PubMed: 358762](https://pubmed.ncbi.nlm.nih.gov/358762)\] 18. Stevenson JC. Current management of malignant hypercalcaemia. Drugs. 1988 Aug;36(2):229-38. \[[PubMed: 3053127](https://pubmed.ncbi.nlm.nih.gov/3053127)\] 19. Masi L, Brandi ML. Calcitonin and calcitonin receptors. Clin Cases Miner Bone Metab. 2007 May;4(2):117-22. \[[PMC free article: PMC2781237](/pmc/articles/PMC2781237/)\] \[[PubMed: 22461211](https://pubmed.ncbi.nlm.nih.gov/22461211)\] 20. Felsenfeld AJ, Levine BS. Calcitonin, the forgotten hormone: does it deserve to be forgotten? Clin Kidney J. 2015 Apr;8(2):180-7. \[[PMC free article: PMC4370311](/pmc/articles/PMC4370311/)\] \[[PubMed: 25815174](https://pubmed.ncbi.nlm.nih.gov/25815174)\] 21. Niall HD, Keutmann HT, Copp DH, Potts JT. Amino acid sequence of salmon ultimobranchial calcitonin. Proc Natl Acad Sci U S A. 1969 Oct;64(2):771-8. \[[PMC free article: PMC223410](/pmc/articles/PMC223410/)\] \[[PubMed: 5261048](https://pubmed.ncbi.nlm.nih.gov/5261048)\] 22. Andreotti G, Méndez BL, Amodeo P, Morelli MA, Nakamuta H, Motta A. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix. J Biol Chem. 2006 Aug 25;281(34):24193-203. \[[PubMed: 16766525](https://pubmed.ncbi.nlm.nih.gov/16766525)\] 23. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest. 1986 Aug;78(2):355-60. \[[PMC free article: PMC423551](/pmc/articles/PMC423551/)\] \[[PubMed: 3016026](https://pubmed.ncbi.nlm.nih.gov/3016026)\] 24. Carstens JH, Feinblatt JD. Future horizons for calcitonin: a U.S. perspective. Calcif Tissue Int. 1991;49 Suppl 2:S2-6. \[[PubMed: 1933616](https://pubmed.ncbi.nlm.nih.gov/1933616)\] 25. Overgaard K, Agnusdei D, Hansen MA, Maioli E, Christiansen C, Gennari C. Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women. J Clin Endocrinol Metab. 1991 Feb;72(2):344-9. \[[PubMed: 1846873](https://pubmed.ncbi.nlm.nih.gov/1846873)\] 26. Reginster JY, Franchimont P. Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin Exp Rheumatol. 1985 Apr-Jun;3(2):155-7. \[[PubMed: 2410171](https://pubmed.ncbi.nlm.nih.gov/2410171)\] 27. Latif A, Gastelum AA, Farhan K, Jagadesh S, Mutnuri S. Treatment approach for primary hyperparathyroidism in pregnancy. Proc (Bayl Univ Med Cent). 2020 Oct 28;34(1):191-193. \[[PMC free article: PMC7785157](/pmc/articles/PMC7785157/)\] \[[PubMed: 33456198](https://pubmed.ncbi.nlm.nih.gov/33456198)\] 28. Peña-Rodríguez ZA, Haro-García M, Benito-Navarro JR. Nasal osteoma and inhaled salmon calcitonin: Coincidence or consequence? Acta Otorrinolaringol Esp (Engl Ed). 2017 Nov-Dec;68(6):366-368. \[[PubMed: 28069111](https://pubmed.ncbi.nlm.nih.gov/28069111)\] 29. Overman RA, Borse M,